Sign in
4

Changes in Ownership

Elicio Therapeutics, Inc. Filed Acc 0001140361-24-005498

Options or other derivatives

  • CEO, President and Director acquired 225,137 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Connelly Robert · CEO, President and Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-02-01 Grant or award : show line 1 in the form Stock Option (right to buy) +225,137 225,137 D
Loading xslF345X05/form4.xml…